Indication DUPIXENT is indicated as an add-on maintenance treatment in adult patients with inadequately controlled chronic rhinosinusitis with nasal polyposis (CRSwNP).As an add-on maintenance treatment in adult patients with inadequately controlled chronic rhinosinusitis with nasal polyposis (CRSwNP).

The materials for DUPIXENT contained in this virtual exhibition are approved for use only in the United States of America. Prescribing information may vary depending on local approval in each country. Therefore, before prescribing any product, always refer to local materials such as the full Prescribing Information and/or the Summary of Product Characteristics (SmPC).

EXPLORE THE FIRST AND ONLY BIOLOGIC FDA-APPROVED IN CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (CRSwNP)

CRSwNP Patient with COMORBID NSAID-ERD

Explore the efficacy and safety profile of DUPIXENT in a CRSwNP patient with comorbid NSAID-ERD

CRSwNP Patient with COMORBID NSAID-ERD

Explore the efficacy and safety profile of DUPIXENT in a CRSwNP patient with comorbid NSAID-ERD

EXPLORE THE MOA

View the science behind the mechanism of action of DUPIXENT

EXPLORE THE MOA

View the science behind the mechanism of action of DUPIXENT

Listen to an expert

Dr Sher: CRSwNP endpoints & data


Dr Sher: CRSwNP pooled analysis

Listen to an expert

Dr Sher: CRSwNP endpoints & data


Dr Sher: CRSwNP pooled analysis

CRSwNP PATIENT WITH
PREVIOUS SINO-NASAL
SURGERY

Explore the efficacy and safety profile of DUPIXENT in a CRSwNP patient with previous sino-nasal surgery

CRSwNP PATIENT WITH
PREVIOUS SINO-NASAL
SURGERY

Explore the efficacy and safety profile of DUPIXENT in a CRSwNP patient with previous sino-nasal surgery

DUPIXENT MyWay®

Enrollment Video: Information to help your appropriate patients with the enrollment process


Delivery Video: See how your appropriate patients can access DUPIXENT

DUPIXENT MyWay®

Enrollment Video: Information to help your appropriate patients with the enrollment process


Delivery Video: See how your appropriate patients can access DUPIXENT

DOSING AND
ADMINISTRATION

Dosing Card

DOSING AND
ADMINISTRATION

Dosing Card

VIEW upper Airway
Inflammation

Download this asset to see the potential of DUPIXENT

VIEW upper Airway
Inflammation

Download this asset to see the potential of DUPIXENT

APPROVED FOR 3 INDICATIONS


EXPLORE ADDITIONAL
INDICATIONS
SWIPE TO EXPLORE